Dr. Michael Park, MD
What this data tells you about Dr. Park
Dr. Michael Park is a medical oncology in Lewisville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Park performed 73,465 Medicare services across 2,872 unique beneficiaries.
Between the years covered by Open Payments, Dr. Park received a total of $5,166 from 39 pharmaceutical and/or device companies across 86 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Park is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 24,400 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 9,345 | $2 | $20 |
| Iron infusion (Feraheme) | 8,160 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 7,000 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) | 5,850 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 5,645 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 4,140 | $18 | $66 |
| Blood draw (venipuncture) | 1,191 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,022 | $8 | $36 |
| Comprehensive metabolic blood panel | 819 | $10 | $64 |
| Dexamethasone injection (steroid) | 810 | $0 | $1 |
| Office visit, established patient (30-39 min) | 521 | $90 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 450 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 420 | $0 | $24 |
| Office visit, established patient (20-29 min) | 357 | $59 | $250 |
| Lactate dehydrogenase (enzyme) level | 285 | $6 | $31 |
| Iron level test | 225 | $6 | $27 |
| Iron binding capacity test | 225 | $9 | $35 |
| Ferritin level test (iron stores) | 224 | $13 | $60 |
| Drug injection, under skin or into muscle | 206 | $10 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 184 | $46 | $313 |
| Administration of chemotherapy into vein, 1 hour or less | 173 | $98 | $707 |
| Injection of additional new drug or substance into vein | 155 | $11 | $108 |
| Basic metabolic blood panel | 147 | $8 | $49 |
| Injection, zoledronic acid, 1 mg | 132 | $6 | $431 |
| Microscopic examination for white blood cells with manual cell count | 118 | $4 | $22 |
| Complete blood count (CBC), automated | 118 | $6 | $34 |
| Red blood count automated, with additional calculations | 64 | $5 | $26 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 62 | $24 | $145 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 61 | $69 | $70 |
| Thyroid stimulating hormone (TSH) test | 59 | $16 | $80 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 59 | $22 | $157 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 59 | $55 | $211 |
| Ct scan of chest with contrast | 58 | $44 | $821 |
| CT scan of abdomen and pelvis with contrast | 58 | $173 | $1,067 |
| Injection, diphenhydramine hcl, up to 50 mg | 46 | $1 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 42 | $45 | $344 |
| Infusion, normal saline solution , 1000 cc | 41 | $2 | $19 |
| Immunoglobulin level test | 39 | $9 | $56 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 39 | $91 | $657 |
| Measurement of immunoglobulin light chains | 38 | $17 | $60 |
| Reticulated (young) platelet measurement | 38 | $35 | $143 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 36 | $1,124 | $4,802 |
| Vitamin B-12 level test | 35 | $15 | $76 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 33 | $1 | $17 |
| Folic acid level test | 32 | $14 | $73 |
| Hospital follow-up visit, moderate complexity | 30 | $61 | $247 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 29 | $16 | $100 |
| Administration of chemotherapy into vein, each additional hour | 29 | $21 | $161 |
| Drawing of blood for a medical problem | 27 | $67 | $264 |
| Infusion into a vein for hydration, 31-60 minutes | 21 | $23 | $256 |
| Office visit, established patient, complex (40-54 min) | 21 | $130 | $496 |
| Infusion into a vein for hydration, each additional hour | 20 | $10 | $75 |
| Irrigation of implanted venous access drug delivery device | 19 | $13 | $114 |
| Beta-2 microglobulin (protein) level | 17 | $16 | $96 |
| Hospital follow-up visit, low complexity | 17 | $38 | $135 |
| New patient office visit (30-44 min) | 14 | $85 | $372 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Park is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and consulting-driven industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Park experienced with iron sucrose injection (venofer)?
Does Dr. Park receive payments from pharmaceutical companies?
How do Dr. Park's costs compare to other medical oncologys in Lewisville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology